Sterling Pharma Solutions buys UK-based NewChem Technologies
NewChem Technologies is a contract services provider and supplies customers in pharmaceuticals, diagnostics and biotechnology to veterinary science…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Oct 23
NewChem Technologies is a contract services provider and supplies customers in pharmaceuticals, diagnostics and biotechnology to veterinary science…
16 Oct 23
With no dose-limiting toxicities observed, treatment of second dose cohort to begin
16 Oct 23
The Company will host an investor event following the presentation after the close of market on Thursday, November 2nd
16 Oct 23
Fezolinetant is an investigational nonhormonal treatment for vasomotor symptoms (VMS) associated with menopause
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Oct 23
Braftovi plus Mektovi is indicated for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) with…
13 Oct 23
By adding the new expanded production line, AGC Biologics can now provide more plasmid material in high-quality and…
13 Oct 23
In the mirikizumab arm of the study, 45.4% of patients achieved clinical response at week 12 and clinical…
13 Oct 23
In the trial, Rinvoq showed a percent change from baseline in the Facial Vitiligo Area Scoring Index at…
13 Oct 23
Under the terms of this agreement, Almirall will gain a license to utilize EpimAb’s proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig)…
13 Oct 23
Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and…